VIVUS Inc
Change company Symbol lookup
Select an option...
VVUS VIVUS Inc
ANY Sphere 3D Corp
LEDCF CRS Electronics Inc
BOOT Boot Barn Holdings Inc
SPIZF Sparebanken Vest
FRED Fred's Inc
CST CST Brands Inc
WYNN Wynn Resorts Ltd
NRX NephroGenex Inc
LNKE Link Energy LLC
Go

Health Care : Pharmaceuticals | Small Cap ValueCompany profile

VIVUS, Inc. is a biopharmaceutical company. The Company is engaged in the development and commercialization of therapeutic products. It provides two therapies approved by the Food and Drug Association (FDA), which include Qsymia (phentermine and topiramate extended-release) for chronic weight management and STENDRA (avanafil) for erectile dysfunction (ED). The Company is also developing and has completed the Phase II studies of Qsymia for the indication of OSA and diabetes. Qsymia is available in over 42,000 certified retail pharmacies across the country. STENDRA is also approved by the European Commission (EC), under the name, SPEDRA, for the treatment of ED in the Europe. As of September 18, 2014, the FDA approved a Supplemental New Drug Application (sNDA) for STENDRA. STENDRA is indicated to be taken approximately 15 minutes before sexual activity.

Price
Delayed
$1.05
Day's Change
0.08 (8.25%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.07
Day's Low
0.9608
Volume
(Heavy Day)

Today's volume of 949,136 shares is on pace to be much greater than VVUS's 10-day average volume of 963,972 shares.

949,136

Unable to locate that news article. Back to news results

Earnings Calendar and Events Data provided by |Terms of Use| © 2016 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by SunGard.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by , Computrade Systems, Inc.,, , and

Copyright © 2016. All rights reserved.